Actinium Pharmaceuticals Inc. (Delaware) (ATNM)
NYSE: ATNMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 10:23 AM ET
ATNM stock chart
Technical analysisKey statistics
All statistics- Market cap
- $33.80M
- P/E (TTM)
- 2.99
- EPS (TTM)
- $0.36
- Dividend yield
- None
- 52-week range
- 0.735 – 1.74
- Day range
- 1.08 – 1.10
- Volume / Avg
- 8.92K / 138.94K
- Beta
- —
- Shares outstanding
- 31.44M
52-week range
ATNM stock today
On Oct 8, ATNM is trading at $1.08, shedding $0.0007 (0.07%), versus the S&P 500's 0.17% decline. At this level, ATNM sits in the middle of its 52-week range of $0.735 to $1.74: 38.2% below the high, set on Oct 24, 2025 and 46.3% above the low. ATNM is down 21.3% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 32.3%.
Actinium Pharmaceuticals (Delaware) trades at 3.0x its trailing twelve-month earnings per share of $0.36.
Summary generated from market data by MetaCap's automated system. Methodology
About Actinium Pharmaceuticals (Delaware)
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Actinium Pharmaceuticals (Delaware) peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NNVCNanoViricides Inc. | 1.32 | -8.21% | $33.70M | vs ATNM |
| RMTIRockwell Medical Inc. | 8.22 | 0.00% | $33.13M | vs ATNM |
| BCTXBriaCell Therapeutics Corp. | 3.94 | -1.50% | $34.28M | vs ATNM |
| IBOImpact BioMedical Inc. | 4.14 | -7.43% | $35.39M | vs ATNM |
| LITSLite Strategy Inc. | 1.21 | -4.72% | $36.80M | vs ATNM |
| GRDXGridAI Technologies Corp. | 4.26 | +3.40% | $30.38M | vs ATNM |
| FLNAFilana Therapeutics Inc. | 0.7788 | -4.52% | $37.62M | vs ATNM |
| RNAZTransCode Therapeutics Inc. | 1.75 | -0.73% | $29.58M | vs ATNM |
Indexes, lists and sector
Actinium Pharmaceuticals (Delaware) stock FAQ
What is Actinium Pharmaceuticals (Delaware)'s stock price today?
ATNM last traded at $1.08 as of Oct 8, 10:23 AM EDT, down 0.07% on the day. Prices are delayed at least 15 minutes.
Does Actinium Pharmaceuticals (Delaware) pay a dividend?
No. Actinium Pharmaceuticals (Delaware) does not currently pay a regular cash dividend.
What is ATNM's P/E ratio?
ATNM trades at a trailing P/E ratio of 2.99.
Has ATNM ever split its stock?
Yes. The most recent ATNM stock split was a 1-for-30 split on Aug 11, 2020.
What is the ATNM 52-week high?
The 52-week high for ATNM is $1.74 and the 52-week low is $0.735. The stock is currently 38.2% below its high.